æ°åã³ããã¦ã¤ã«ã¹ã«è² ããªãï¼ä¸å½é¼ç¸å¦ä¼ã¯ãCOVID-19ã®ããã®é¼ç¸ä»å ¥ã¬ã¤ãã©ã¤ã³ï¼ç¬¬2çï¼ããä½æ â»æ°åã³ããã¦ã¤ã«ã¹ææçé¢é£ãªã³ã¯ããåèãã ããã â»æ°åã³ããã¦ã¤ã«ã¹ææçã®è診ã«ã¤ãã¦ãã覧ãã ããã â»ãCOVID-19ã«é¢ããå½éè¬åº§ï¼å½éå°å®¶æç«å¤§è¬å ï¼ãããªã³ã©ã¤ã³è¬åº§ã¨ãã¦éå¬ãã覧ãã ããã -------------------------------------------------------------------------------- ä¸å½é¼ç¸å¦ä¼ãCOVID-19ã®ããã®é¼ç¸ä»å ¥ã¬ã¤ãã©ã¤ã³ï¼ç¬¬2çï¼ãï¼ç·¨éé¨è¨³ï¼ 3æ2æ¥ãæ°åã³ããã¦ã¤ã«ã¹ã¨ã®æ¦ãã«ããã¦ãä¸å½é¼ç¸å¦ä¼ã¯ãCOVID-19ã®ããã®é¼ç¸ä»å ¥ã¬ã¤ãã©ã¤ã³ï¼ç¬¬2çï¼ããä½æããä¸çé¼ç¸é£åä¼ï¼WFASï¼ãéãã¦çºè¡¨ãããç·¨éé¨ã®è¨³ãæ²è¼ããã â»æ°åã³ããã¦ã¤ã«ã¹æµè¡å è¡å½
å ¨æ¥æ¬é¼ç¸ï¼ãããã ãï¼å¦ä¼ãªã©ï¼å£ä½ã¯ï¼æ¥ãæ²¢ææä¸ææã®æ éãçå£ãã¬ã¼ãã¼ã®ã¯ãæ²»çã§ã®æ½è¡ãã¹ã«ããå¯è½æ§ãé«ãã¨ãã¦ãã巨人ã«å¯¾ãã¦éä»ããå ¬é質åç¶ã«å¯¾ããåçæ¸ãï¼æ¥ã«åãåã£ãã¨ããå 容ãå ¬éããã å 容ã¯æ¬¡ã®éãã å çãè²´å£ä½ããï¼æï¼ï¼æ¥ä»ææ¸ãã¯ãæ²»çã«ããé·è¸ç¥çµéº»çºã«é¢ããå ±éã«ã¤ãã¦ã®ç §ä¼ããå½çå£ã«ééããããã¨ãåãã¦ãå½çå£ã¯å½è©²é¸æã診å¯ããè¤æ°ã®å»å¸«ãããããããã¦ã話ãããããã¾ããã ãããã®å»å¸«ããé¸æã®çç¶çããé·è¸ç¥çµã®ä¸å ¨éº»çºã§ãããããã«ä¼´ãåé¸çã®æ©è½ä½ä¸ã§ããã¨ã®è¨ºæã«å¤ããã¯ãªãã¨è©±ããã¦ãã¾ããã¾ããçºçææãå½è©²é¸æã®å診çãããé·è¸ç¥çµã®éº»çºã¯ãå½çå£ã®ãã¬ã¼ãã¼ãè¡ã£ãé¼æ²»çãåå ã¨ãªã£ãå¯è½æ§ãèããããã¨çãããã¾ããããã ããé¼æ²»ç以å¤ã«ããå¼·ãåããããä»ã®å¤çè¦å ã«ãã£ã¦é·è¸ç¥çµã®éº»çºãçããå¯è½æ§ãããã¨ã®æè¦
ç¾å®¹ããªãæè¿ã²ããã«å¥³æ§ãã¡ã®éã§è©±é¡ã«ãªã£ã¦ããããå®éã®ã¨ãããã®å¹æã¨å®å ¨æ§ã«ã¤ãã¦æ°ã«ãªã£ã¦ãã人ãå¤ãããã ã çè ã¯è¥¿æ´å»å¦ãç¤ã¨ããæ¶åå¨å¤ç§ã®å»å¸«ã ããé¼ç¸å»çãå«ããããã代æ¿å»çã«ä»¥åããèå³ãæã£ã¦ãããçç±ã¯ãããã¾ã§ã®å»è çµé¨ã®ä¸ã§ã西æ´å»å¦ã§æ²»ããªããã®ã®åå¨ãçåã«ç¥ãããçè«ç説æãã¤ããªãã¨ãå¹æã®ãããã®ã¯ä½¿ãã¹ãã§ãããã¨èãã¦ããããã ã ãã®èå³ãããååã西æ´å»å¦ã®å»è ãããªæ²»çãåãã¦æãããã¨ãã¨ããè¨äºã§å®éã«çè èªèº«ãçµé¨ããé¼ç¸æ²»çã«ã¤ãã¦ãªãã¹ã客観çã«è©ä¾¡ããã¨ã¨ãã«ãå®å ¨æ§ã«ã¤ãã¦å»å¦çè¦å°ããèå¯ããã ä»åã¯ãã®å»¶é·ä¸ã®æ¤è¨ã ããæè¿è©±é¡ã«ãªã£ã¦ãããç¾å®¹é¼ãã«ã¤ãã¦èªèº«ãçµé¨ããããã«ååã®å¥³æ§å¤ç§å»ã¸ã®æ²»çã観å¯ããã ä¸ã¤ãã®æ¤è¨ã®åé¡ç¹ãããããç¾å®¹å¹æãï¼ãããªã§ã©ãããããã¬ã¤ã«ãªã£ãã®ããã¯å®¢è¦³çãªè©ä¾¡ãé£ãã
3ï¼é¼ç¸æ²»çã®ç§å¦çæ ¹æ ç§å¦çæ ¹æ ã¨ã¯ ç§å¦ã¯ãç¾è±¡ã®ã¡ã«ããºã ï¼æ©åºï¼ãæããã«ããäºãç®çã¨ãã¾ãã ç 究è ã¯ã仮説ãç«ã¦ã仮説ã«åºã¥ããå®é¨ãç¹°ãè¿ãã¾ãã仮説ã証æããã®ã«ååãªãã¼ã¿ãå¾ããããããããè«æåãã¾ããè«æã¯ç§å¦è«æéèªã«æ稿ãããç§å¦çè¦å°ã§ååæ ¹æ ã¨ãªããã審æ»ããã¾ããç§å¦è«æéèªã¯æ°å¤ãããã¾ãããã©ã³ã¯ããããã©ã³ã¯ãé«ãæ¹ã»ã©ãæ²è¼ãããã®ãå³ããããã®åãæ²è¼ãããã°ãä¿¡é ¼æ§ã®é«ãç§å¦çæ ¹æ ã¨ãã¦èªãããã¾ãã å»å¦ç³»è«æã®ãã¼ã¿ãã¼ã¹ã§ããPubmedã§acupunctureï¼é¼æ²»çï¼ãæ¤ç´¢ããã¨ã2ä¸ä»¶ä»¥ä¸ã®è«æãããããã¾ãã ãã®ä¸ã§ã権å¨ããéèªã«æ²è¼ããã代表çãªè«æã3ã¤ç´¹ä»ãã¾ãã é¼ç¸ã«é¢ãã代表çãªç§å¦è«æ 1. Adenosine A1 receptors mediate local anti-nociceptive effec
è©ããã§ãå°ãã®æ¹ã¸ ãã®ãããªçç¶ã§ãå°ãã§ã¯ããã¾ãããï¼ ä»äºã§ãã½ã³ã³ä½æ¥ãå¤ãè©ããã è©ããã ãã§ã¯ãªããé çããã è©ãããæ¾ã£ã¦ãããããæã«ãã³ããåºã¦ãã ã®ã¼ããæãããã ç®ã®ç²ãããè©ããã èä¸ã®è©ç²éª¨ã¾ãããçã è©ããã®åå è©ããçºçã®ã¡ã«ããºã ç²å´ã»ã¹ãã¬ã¹ â èªå¾ç¥çµã®ä¹±ã â çèã®ç·å¼µãè¡è¡ä¸è¯ â è©ãããçã¿ãçºç â ãããªãã¹ãã¬ã¹ï¼ç¹°ãè¿ãï¼ è©ããã®ä¸çªã®åå ã¯ç²å´ã¨ã¹ãã¬ã¹ã§ããããã«ãã£ã¦ãçèãç·å¼µãããè¡è¡ãæªããªã£ãããã¦è©ããã«ãªãã¾ãã è©ãããå¼·ãã¨ããèªä½ãã¹ãã¬ã¹ã«ãªãã¾ãã®ã§ãããã«è©ãããæªåããã¨ããæªå¾ªç°ãçã¾ãã¾ãã è©ãããæªåããã¨ãçã¿ã«å¤ãã£ãããæã®ãã³ãããã¾ããé çãªã©ã®çç¶ãåºããã¨ãããã¾ãã è©ããã¨å§¿å¢ã»ä½ã®ããã¿ è©ããã®åå ã«æãå½ãããã¨ã¯ããã¾ããï¼ãã質åããã¨ãã»ã¼å ¨å¡
ããæã¯éããã®ãæã£ãç¬éã«ãã¾ãããæã¯ãããã¿ãããç¬éã«ãè °ã«å¼·çãªçã¿ãåºã¦èº«åããåããªããªããããããã£ããè °ã§ããå»å¦çã«ã¯æ¥æ§è °çã¨å¼ã°ãã¾ããããã§ã¯ããã£ããè °ã¨ã¯ä½ãªã®ããé¼ç¸ã§æ¹åããã®ã¯ä½æ ãªã®ããè¦ã¦ããã¾ãã ãã£ããè °ã¨ã¯ ããããã®ã¯ããã£ããè °ã¯çèã®ççã§ãããã¨ããééãã§ããå»å¦çã«ççã¨ã¯ãç¼çãçºèµ¤ãè «è¹ãçºç±ãæ©è½é害ãã®5ã¤ãããã£ãç¶æ ãããã¾ãããã£ããè °ã®å ´åã赤ãè «ããã¨ãããã¨ã¯ããã¾ããã®ã§ãççã§ã¯ããã¾ãããççæã«è¡æ¶²æ¤æ»ãããã¨CRPã¨ããæ°å¤ãä¸ããã¾ãããããããåå¿ã¯ãã£ããè °ã§ã¯è¦ããã¾ãããççã¯çµç¹ã«æå·ããªãã¨èµ·ããã¾ããã®ã§ããã£ããè °ã¯ã©ããªã«çãã¦ãçèã®ãã¡ã¼ã¸ã¯ãªãã¨ãããã¨ã§ããï¼çèãæå·ãããã®ã¯èé¢ãã¨ãã¦åºå¥ããã¾ããï¼ ã¾ãã骨ã®ç°å¸¸ãåå ã ã¨ããã®ãééãã§ããä¾ãã°ãã¡ãã£ã¨ä½ã
é¼ç¸ã®å¹æã«ã¤ã㦠é¼ç¸ã¯ãå¤ä»£ä¸å½ããå§ã¾ã£ãä¼çµ±çãªæ±æ´å»å¦ã®ä¸ã¤ã§ãããéãåºãã¦èº«ä½ã®ãã©ã³ã¹ãæ´ãããã¨ã«ãã£ã¦ããã¾ãã¾ãªç æ°ãçç¶ãæ²»çããã¨ããã¦ãã¾ãã ä¸è¬çã«ã¯ãé¼ç¸ã¯çã¿ãã¹ãã¬ã¹ã®ç·©åãå ç«åã®åä¸ãä¸ç çããã¤ç ãä¸å¦çãªã©ã®çç¶ã®æ¹åã«å¹æãããã¨ããã¦ãã¾ããã¾ããé¼ç¸ã«ãã£ã¦è¡è¡ããªã³ãã®æµããæ¹åããããã¨ã§ãççã®ç·©åã代è¬ã®ä¿é²ãå ç«åã®åä¸ã«ã¤ãªããã¨ããã¦ãã¾ãã ããã«ãæè¿ã®ç 究ã«ãããé¼ç¸ãè³å ã®ç¥çµä¼éç©è³ªã®æ¾åºãä¿é²ãããã¨ã§ãçã¿ã®è»½æ¸ãä¸å®ããã¤çç¶ã®æ¹åã«ãå¹æããããã¨ã示ããã¦ãã¾ãã ãã ããé¼ç¸ã®å¹æã«ã¤ãã¦ã¯ãå人差ãããã¾ãããå»å¦çãªæ ¹æ ãä¸ååãªå ´åãããã¾ãããããã£ã¦ãé¼ç¸ãåããéã«ã¯ãçµé¨è±å¯ãªé¼ç¸å¸«ã«ããé©åãªæ½è¡ãåãããã¨ãéè¦ã§ããã¾ããç æ°ãçç¶ãããå ´åã«ã¯ãå°é家ã®æå°ãåãããã¨ãå¿ è¦ã§ãã
The .gov means itâs official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure youâre on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ä»æ¥ã¯ï¼æï¼ï¼æ¥ããã¯ã¤ããã¼ã§ãããã¡ããã©ï¼ã¶æåã®2æï¼ï¼æ¥ã®ãã¬ã³ã¿ã¤ã³ãã¼ã«ç±³å½å ç§å¦ä¼ãå ¬è¡¨ããè °çæ²»çã«é¢ããã¬ã¤ãã©ã¤ã³ã®èå³æ·±ãè¨è¿°ã«ã¤ãã¦ãä»åã¯è¦ã¦ããããã¨æãã¾ãã ãã®ã¬ã¤ãã©ã¤ã³ã§ã¯ãè °çæ²»çã«é¢ãã¦ï¼ã¤ã®æ¨å¥¨ï¼Recommendationï¼ãåºãã¦ãã¾ãã Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2017 Feb 14 https://www.ncbi.nlm.nih.gov/pubmed/28192789 å°ãé·ããªãã¾ãããä¸ã¤ãã¤ã¿ã¦ããã¾ãããã âæ¨å¥¨1ï¼æ¥æ§ã¾ãã¯äºæ¥æ§ã®è °çã
æ¤éæ¿ãã«ãã¢ã¨ã¯ è骨ã¯æ¤éª¨ã¨ãã骨ã縦ã«ã¤ãªãã£ã¦ã§ãã¦ãã¾ãããã®æ¤éª¨ã¨æ¤éª¨ã®éã«ããã¯ãã·ã§ã³ãæ¤éæ¿ã¨ããããã®æ¤éæ¿ã横ã«è¨ããã ãé£ã³åºããããããã®ãæ¤éæ¿ãã«ãã¢ã¨ããã¾ãããã«ãã¢ã¯é£ã³åºãã¨ããæå³ã§ãã ããæ¸ãã¨ãæ¤éæ¿ãé£ã³åºããªãã¦å¤§å¤ã ã¨æãããããããã¾ãããããããæ¤éæ¿ãã«ãã¢ã¯ãããªã«çããç¾è±¡ã§ã¯ããã¾ãããããã¾ã§æ°å¤ãã®å»å¦èª¿æ»ãããã¦ãã¾ããããå¥åº·ãªäººã§ãç´76ï¼ ã«æ¤éæ¿ãã«ãã¢ãè¦ã¤ãããã¨ãåãã£ã¦ãã¾ãããã«ãã¢ãããããç æ°ã¨ããããã§ã¯ããã¾ããã çã¿ã®æ²»çã§æåãªå èæ´å½¢å¤ç§ã®å èæ·³å çã¯ãèæ¸ã®ãªãã§âãæ¤éæ¿ãç¥çµãå§è¿«ãã¦ãçã¿ã¯çããªããã¨ããã®ã¯ããã¯ãå»å¦çäºå®ã§ããâã¨è¿°ã¹ã¦ãã¾ãã æè¡ãå¿ è¦ãªæ¤éæ¿ãã«ãã¢ã¯ããä¸é¨ã ã æ¤éæ¿ãã«ãã¢ã§æè¡ãå¿ è¦ã«ãªãã®ã¯ã»ãã®3ï¼ ç¨åº¦ã§ããã»ã¨ãã©ã®ãã«ãã¢ã¯å¿é ãããªã
è °çæ£è ï¼ï¼ï¼åã¨å¥å¸¸è ï¼ï¼ï¼åã対象ã«éª¨ç¤ã®æªã¿ãå³å¯ã«æ¸¬å®ãã¦è °çã¨ã®é¢é£ã調ã¹ãçµæãã©ã®ãããªè¨åºçæ義ã«ããã¦ã骨ç¤ã®é対称æ§ã¨è °çã¯é¢é£ãã¦ããªããã¨ãå¤æã骨ç¤ã®æªã¿ãè °çã®åå ã¨ããã®ã¯è¿·ä¿¡ã«éããªããhttp://t.co/iEvQzim åãå ¥ããããå»çé¢ä¿è ãå¤ãã§ããããããã®çµæã«ç°ãå±ããããã°åãç 究ããã£ã¦ã¿ããã¨ã§ããèªç¶çã«å·¦å³å¯¾ç§°ã¯åå¨ãã¾ããããã信念ã«åºå·ãã¦äºå®ããç®ãããããã¨ã確証ãã¤ã¢ã¹ã¨ããã¾ãã å½æ°ã®å©çã«ãªãããããã¾ããããããè¿·æã§ãªããã°ãã·ã§ã¢ãããé¡ãè´ãããåãã¾ãããã¡ãã¡æ¿è«¾ãå¾ãå¿ è¦ããªããã°ãï¼´ï¼ï¼³ã¸ã£ãã³ãææã®ååãåºãå¿ è¦ã¯ããã¾ããã®ã§ãSNSã¯ãã¡ããããã°ããµã¤ãã«å¼ç¨å ã®ï¼µï¼²ï¼¬ãã¨ã³ãã¼ï¼ãã¼ã¹ããã¦ãæ å ±ã®æ¡æ£ã«ãåã貸ãã¦ããã ããã¨å¹¸çã§ãããã¾ãã
é¦ãè©ãè¶³è °ãªã©ç¹å®ã®å ´æã«çã¿ãæãã¦ãã人ã¯å¤ããã¾ãããããç é¢ã«è¡ã£ã¦ã¬ã³ãã²ã³ãæ®ã£ã¦ããã£ãããå ´åã«ãã£ã¦ã¯CTãMRIãæ®ã£ã¦ããã£ãããã¦ããä½ã®åé¡ãã¿ã¤ãããªããã¨ãããã¾ãã è¿å¹´ãä»ã¾ã§ã¯åå ä¸æã¨è¨ããã¦ããçã¿ããå®ã¯çèæ§ç¼ççå群ï¼ããã¾ãããã¨ãã¤ããããããããï¼Myofascial Pain Syndrome : MPSï¼ã«ãããã®ã§ãããã¨ãåãã£ã¦ãã¾ãããçèæ§ç¼ççå群ã«ã¤ãã¦ãé å²å³¶åç é¢é¢é·ã®ç½ç³å彦å çã«è©³ãããèããã¾ããã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}